Literature DB >> 24338497

Prognostic value of estimated glomerular filtration rate in hospitalized elderly patients.

Laura De La Higuera1, Emma Riva, Codjo Djignefa Djade, Sara Mandelli, Carlotta Franchi, Alessandra Marengoni, Francesco Salerno, Salvatore Corrao, Luca Pasina, Mauro Tettamanti, Maura Marcucci, Pier Mannuccio Mannucci, Alessandro Nobili.   

Abstract

A multicenter observational study, REPOSI (REgistro POliterapie Società Italiana di Medicina Interna), was conducted to assess the prognostic value of glomerular filtration rate (eGFR) on in-hospital mortality, hospital re-admission and death within 3 months, in a sample of elderly patients (n = 1,363) admitted to 66 internal medicine and geriatric wards. Based on eGFR, calculated by the new Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula, subjects at hospital admission were classified into three groups: group 1 with normal eGFR (≥60 ml/min/1.73 m(2), reference group), group 2 with moderately reduced eGFR (30-59 ml/min/1.73 m(2)) and group 3 with severely reduced eGFR (<30 ml/min/1.73 m(2)). Patients with the lowest eGFR (group 3) on admission were more likely to be older, to have a greater cognitive and functional impairment and a high rate of comorbidities. Multivariable logistic regression analysis showed that severely reduced eGFR at the time of admission was associated with in-hospital mortality (OR 3.00; 95% CI 1.20-7.39, p = 0.0230), but not with re-hospitalization (OR 0.97; 95% CI 0.54-1.76, p = 0.9156) or mortality at 3 months after discharge (OR 1.93; 95% CI 0.92-4.04, p = 0.1582). On the contrary, an increased risk (OR 2.60; 95% CI 1.13-5.98, p = 0.0813) to die within 3 months after discharge was associated with decreased eGFR measured at the time of discharge. Our study demonstrates that severely reduced eGFRs in elderly patients admitted to hospital are strong predictors of the risk of dying during hospitalization, and that this measurement at the time of discharge helps to predict early death after hospitalization.

Entities:  

Mesh:

Year:  2013        PMID: 24338497     DOI: 10.1007/s11739-013-1028-5

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  31 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  A multi-institutional, hospital-based assessment of clinical, functional, sociofamilial and health-care characteristics of polypathological patients (PP).

Authors:  M Bernabeu-Wittel; B Barón-Franco; J Murcia-Zaragoza; A Fuertes-Martín; C Ramos-Cantos; A Fernández-Moyano; F J Galindo; M Ollero-Baturone
Journal:  Arch Gerontol Geriatr       Date:  2011-01-07       Impact factor: 3.250

3.  Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study.

Authors:  Alessandro Nobili; Giuseppe Licata; Francesco Salerno; Luca Pasina; Mauro Tettamanti; Carlotta Franchi; Luigi De Vittorio; Alessandra Marengoni; Salvatore Corrao; Alfonso Iorio; Maura Marcucci; Pier Mannuccio Mannucci
Journal:  Eur J Clin Pharmacol       Date:  2011-01-11       Impact factor: 2.953

4.  Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems.

Authors:  Kirsten K Viktil; Hege S Blix; Tron A Moger; Aasmund Reikvam
Journal:  Br J Clin Pharmacol       Date:  2006-08-30       Impact factor: 4.335

5.  Anemia and cardiovascular disease, hospitalization, end stage renal disease, and death in older patients with chronic kidney disease.

Authors:  Shuling Li; Robert N Foley; Allan J Collins
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

6.  Bedside estimation of the glomerular filtration rate in hospitalized elderly patients.

Authors:  Heinrich Burkhardt; Thomas Hahn; Norbert Gretz; Rainer Gladisch
Journal:  Nephron Clin Pract       Date:  2005-05-09

7.  Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study.

Authors:  Manjula Kurella; Glenn M Chertow; Linda F Fried; Steven R Cummings; Tamara Harris; Eleanor Simonsick; Suzanne Satterfield; Hilsa Ayonayon; Kristine Yaffe
Journal:  J Am Soc Nephrol       Date:  2005-05-11       Impact factor: 10.121

Review 8.  Risk factors for hospital readmissions in elderly patients: a systematic review.

Authors:  L García-Pérez; R Linertová; A Lorenzo-Riera; J R Vázquez-Díaz; B Duque-González; A Sarría-Santamera
Journal:  QJM       Date:  2011-05-10

9.  [Renal failure is an independent predictor of mortality in hospitalized heart failure patients and is associated with a worse cardiovascular risk profile].

Authors:  Lilian Grigorian Shamagian; Alfonso Varela Román; Milagros Pedreira Pérez; Inés Gómez Otero; Alejandro Virgós Lamela; José R González-Juanatey
Journal:  Rev Esp Cardiol       Date:  2006-02       Impact factor: 4.753

10.  Comparison of estimated glomerular filtration rate with estimated creatinine clearance in the dosing of drugs requiring adjustments in elderly patients with declining renal function.

Authors:  William J Spruill; William E Wade; Henry H Cobb
Journal:  Am J Geriatr Pharmacother       Date:  2008-08
View more
  7 in total

Review 1.  Kidney disease in heart failure: the importance of novel biomarkers for type 1 cardio-renal syndrome detection.

Authors:  Alberto Palazzuoli; Peter A McCullough; Claudio Ronco; Ranuccio Nuti
Journal:  Intern Emerg Med       Date:  2015-05-14       Impact factor: 3.397

2.  Looking at the kidney to predict global outcome in the elderly.

Authors:  Francesca Viazzi; Elena Ratto; Giovanna Leoncini; Roberto Pontremoli
Journal:  Intern Emerg Med       Date:  2014-06-18       Impact factor: 3.397

Review 3.  Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register.

Authors:  Pier Mannuccio Mannucci; Alessandro Nobili; Luca Pasina
Journal:  Intern Emerg Med       Date:  2018-08-31       Impact factor: 3.397

Review 4.  Multimorbidity and polypharmacy in the elderly: lessons from REPOSI.

Authors:  Pier Mannuccio Mannucci; Alessandro Nobili
Journal:  Intern Emerg Med       Date:  2014-08-28       Impact factor: 3.397

5.  Chronic kidney disease as a predictor of clinical risk in the elderly.

Authors:  Francesca Viazzi; Francesca Cappadona; Barbara Bonino; Roberto Pontremoli
Journal:  J Geriatr Cardiol       Date:  2016-03       Impact factor: 3.327

6.  The association between geriatric treatment and 30-day readmission risk among medical inpatients aged ≥75 years with multimorbidity.

Authors:  Marte Sofie Wang-Hansen; Hege Kersten; Jūratė Šaltytė Benth; Torgeir Bruun Wyller
Journal:  PLoS One       Date:  2022-01-07       Impact factor: 3.240

7.  Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older Patients.

Authors:  Chiara Mussi; Ilaria Ardoino; Carlotta Franchi; Giulia Lancellotti; Marco Bertolotti; Simona Di Salvatore; Alessandro Nobili; Pier Mannuccio Mannucci
Journal:  Clin Interv Aging       Date:  2021-07-02       Impact factor: 4.458

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.